Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Dec;35(12):3132–3139. doi: 10.1128/jcm.35.12.3132-3139.1997

Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks.

Y Zhang 1, M Rajagopalan 1, B A Brown 1, R J Wallace Jr 1
PMCID: PMC230136  PMID: 9399508

Abstract

Mycobacterium abscessus is an important cause of water-related nosocomial outbreaks or pseudo-outbreaks. Strain comparison has relied on pulsed-field gel electrophoresis (PFGE). Unfortunately, almost 50% of strains cannot be assessed by this method. We studied 118 strains of M. abscessus previously studied by PFGE by randomly amplified polymorphic DNA (RAPD) PCR, including isolates from eight nosocomial outbreaks. Ten random primers were evaluated by using DNA prepared by boiling or phenol-chloroform extraction. Both DNA preparations gave the same grouping of isolates for three outbreaks compared to the groupings obtained by PFGE. Five outbreaks due to M. abscessus which gave broken DNA by PFGE gave evaluable patterns when studied by RAPD-PCR, with isolate clustering being consistent with that from other laboratory and epidemiologic data. The patterns were highly method dependent, strain comparison required the use of multiple primers, and the method worked best with purified DNA and by using strains for comparison on the same gel. We propose categories of indistinguishable, different, and inconclusive when comparing strains by RAPD-PCR. This study demonstrates that RAPD-PCR can be used for genetic comparison of M. abscessus strains, including strains which cannot be compared by PFGE, but the potential for misinterpretation is greater than that by PFGE.

Full Text

The Full Text of this article is available as a PDF (2.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abed Y., Davin-Regli A., Bollet C., De Micco P. Efficient discrimination of Mycobacterium tuberculosis strains by 16S-23S spacer region-based random amplified polymorphic DNA analysis. J Clin Microbiol. 1995 May;33(5):1418–1420. doi: 10.1128/jcm.33.5.1418-1420.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bolan G., Reingold A. L., Carson L. A., Silcox V. A., Woodley C. L., Hayes P. S., Hightower A. W., McFarland L., Brown J. W., 3rd, Petersen N. J. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis. 1985 Nov;152(5):1013–1019. doi: 10.1093/infdis/152.5.1013. [DOI] [PubMed] [Google Scholar]
  3. Brown B. A., Wallace R. J., Jr, Onyi G. O., De Rosas V., Wallace R. J., 3rd Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother. 1992 Jan;36(1):180–184. doi: 10.1128/aac.36.1.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burns D. N., Wallace R. J., Jr, Schultz M. E., Zhang Y. S., Zubairi S. Q., Pang Y. J., Gibert C. L., Brown B. A., Noel E. S., Gordin F. M. Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation. Am Rev Respir Dis. 1991 Nov;144(5):1153–1159. doi: 10.1164/ajrccm/144.5.1153. [DOI] [PubMed] [Google Scholar]
  5. Carson L. A., Bland L. A., Cusick L. B., Favero M. S., Bolan G. A., Reingold A. L., Good R. C. Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol. 1988 Dec;54(12):3122–3125. doi: 10.1128/aem.54.12.3122-3125.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carson L. A., Petersen N. J., Favero M. S., Aguero S. M. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol. 1978 Dec;36(6):839–846. doi: 10.1128/aem.36.6.839-846.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hector J. S., Pang Y., Mazurek G. H., Zhang Y., Brown B. A., Wallace R. J., Jr Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J Clin Microbiol. 1992 May;30(5):1250–1255. doi: 10.1128/jcm.30.5.1250-1255.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kauppinen J., Mäntyjärvi R., Katila M. L. Random amplified polymorphic DNA genotyping of Mycobacterium malmoense. J Clin Microbiol. 1994 Jul;32(7):1827–1829. doi: 10.1128/jcm.32.7.1827-1829.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kuritsky J. N., Bullen M. G., Broome C. V., Silcox V. A., Good R. C., Wallace R. J., Jr Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med. 1983 Jun;98(6):938–939. doi: 10.7326/0003-4819-98-6-938. [DOI] [PubMed] [Google Scholar]
  10. Linton C. J., Jalal H., Leeming J. P., Millar M. R. Rapid discrimination of Mycobacterium tuberculosis strains by random amplified polymorphic DNA analysis. J Clin Microbiol. 1994 Sep;32(9):2169–2174. doi: 10.1128/jcm.32.9.2169-2174.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lowry P. W., Jarvis W. R., Oberle A. D., Bland L. A., Silberman R., Bocchini J. A., Jr, Dean H. D., Swenson J. M., Wallace R. J., Jr Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. N Engl J Med. 1988 Oct 13;319(15):978–982. doi: 10.1056/NEJM198810133191504. [DOI] [PubMed] [Google Scholar]
  12. Maloney S., Welbel S., Daves B., Adams K., Becker S., Bland L., Arduino M., Wallace R., Jr, Zhang Y., Buck G. Mycobacterium abscessus pseudoinfection traced to an automated endoscope washer: utility of epidemiologic and laboratory investigation. J Infect Dis. 1994 May;169(5):1166–1169. doi: 10.1093/infdis/169.5.1166. [DOI] [PubMed] [Google Scholar]
  13. Schulze-Röbbecke R., Janning B., Fischeder R. Occurrence of mycobacteria in biofilm samples. Tuber Lung Dis. 1992 Jun;73(3):141–144. doi: 10.1016/0962-8479(92)90147-C. [DOI] [PubMed] [Google Scholar]
  14. Silcox V. A., Good R. C., Floyd M. M. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol. 1981 Dec;14(6):686–691. doi: 10.1128/jcm.14.6.686-691.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Swenson J. M., Thornsberry C., Silcox V. A. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother. 1982 Aug;22(2):186–192. doi: 10.1128/aac.22.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Swenson J. M., Wallace R. J., Jr, Silcox V. A., Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985 Dec;28(6):807–811. doi: 10.1128/aac.28.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995 Sep;33(9):2233–2239. doi: 10.1128/jcm.33.9.2233-2239.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tyler K. D., Wang G., Tyler S. D., Johnson W. M. Factors affecting reliability and reproducibility of amplification-based DNA fingerprinting of representative bacterial pathogens. J Clin Microbiol. 1997 Feb;35(2):339–346. doi: 10.1128/jcm.35.2.339-346.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Villanueva A., Calderon R. V., Vargas B. A., Ruiz F., Aguero S., Zhang Y., Brown B. A., Wallace R. J., Jr Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis. 1997 Jun;24(6):1147–1153. doi: 10.1086/513656. [DOI] [PubMed] [Google Scholar]
  20. Wallace R. J., Jr, Brown B. A., Onyi G. O. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother. 1991 Apr;35(4):773–775. doi: 10.1128/aac.35.4.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wallace R. J., Jr, Meier A., Brown B. A., Zhang Y., Sander P., Onyi G. O., Böttger E. C. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother. 1996 Jul;40(7):1676–1681. doi: 10.1128/aac.40.7.1676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wallace R. J., Jr, Zhang Y., Brown B. A., Fraser V., Mazurek G. H., Maloney S. DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol. 1993 Oct;31(10):2697–2701. doi: 10.1128/jcm.31.10.2697-2701.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES